Analyst firms · Morgan Stanley · SDGR
Morgan Stanley SDGR price target and rating history
Schrodinger Inc. (SDGR) · Health Care
Morgan Stanley rates Schrodinger Inc. (SDGR) Equal-Weight with a $28 price target, as of its latest action on Jul 3, 2025. It has published 3 rating actions on SDGR since September 2021, including 1 upgrade and 1 downgrade.
- Current rating
- Equal-Weight
- Price target
- $28
- Median target, all firms
- Too few
- Actions on SDGR
- 3
Morgan Stanley price target on SDGR
Every Morgan Stanley rating on SDGR
- Jul 3, 2025
- Nov 19, 2021
- Sep 1, 2021
How other firms rate SDGR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Neutral | $19 | Aug 14, 2026 |
| BofA Securities | Buy | $24 | Dec 15, 2025 |
Questions about Morgan Stanley and SDGR
- What is Morgan Stanley's price target for SDGR?
- Morgan Stanley's latest stated price target for Schrodinger Inc. (SDGR) is $28, from its action on Jul 3, 2025.
- What is Morgan Stanley's rating on SDGR?
- Morgan Stanley rates SDGR Equal-Weight, a neutral rating, as of Jul 3, 2025.
- When did Morgan Stanley last change its view on SDGR?
- On Jul 3, 2025, Morgan Stanley resumes coverage at Equal-Weight, price target $28.
All Morgan Stanley ratingsSDGR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.